Recombinant Immunotoxins Containing Truncated Bacterial Toxins for the Treatment of Hematologic Malignancies
MicroRNA-Based Therapeutics for Cancer
Targeted Therapies for Malignant Glioma
Outcomes of New Quality Standards of Follitropin Alfa on Ovarian Stimulation
Pharmacokinetic and Pharmacodynamic Profile of New Biosimilar Filgrastim XM02 Equivalent to Marketed Filgrastim Neupogen®
Ustekinumab
Spotlight on Peginterferon-α-2a (40 kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection†